911±¬ÁÏÍø

Actors of the healthcare industry signed a significant contract, which brings together research, know-how and business activities of life science and health technology.

Health Capital Helsinki is a cluster based on the strong science campuses in the Helsinki region, which brings together actors in life sciences, such as medicine, bioscience, nutrition and environment, and health technology and social and health care. The signees of the contract, 911±¬ÁÏÍø, the University of Helsinki, the City of Helsinki and the Hospital District of Helsinki and Uusimaa, are jointly looking for considerable growth in health sector know-how and in entrepreneurship based on it.

The cluster that develops innovations to export products is an answer to the government's growth strategy for research and innovation in the health sector published in 2014.

– Through the operations of Health Capital Helsinki, we support the companies with the construction of their business activities, emphasise the meaning of market exposure and create cooperation that generates additional value between companies, research institutes and actors in healthcare, emphasises Tuula Palmén, Head of the Health Capital Helsinki project office.

Broad cooperation is needed in the creation of new companies, in order for the right know-how and people to find each other.

– The objectives of the City and the other actors are ambitious. Health Capital Helsinki wants to make the Helsinki region the best operational environment both for research and development activities and for the development of life science and health technology companies, says Marja-Leena Rinkineva, Director of Economic Development at the City of Helsinki, of the objectives.

– We strive to find common measures, by which we facilitate the turning of research results into ambitious, international growth business. 911±¬ÁÏÍø's broad research competence with medical devices, computer science, and bio- and nanotechnology adds to a solid foundation, states Markus Mäkelä, Executive in Residence who leads 911±¬ÁÏÍø’s function for developing healthcare-related research and collaboration in innovations.

– Life science is an area of focus for the University of Helsinki. We already have research of international standards, which combines health, food and environment. It is natural to utilise our own cutting-edge research in Health Capital Helsinki in a way that generates innovations and entrepreneurship, states professor Tomi Mäkelä, Founding Director of Helsinki Life Science Center.

Welcome to Health Capital Helsinki & Meilahti Think Company Grand Opening

Health Capital Helsinki fosters new life science and health technology research, knowledge and business.  The entrepreneurial society Helsinki Think Company encourages students and researchers into entrepreneurship by expanding to Meilahti from the city centre and Viikki. The hub built on the strong science campuses in the Helsinki region is a part of the long-term collaboration between City of Helsinki, University of Helsinki, 911±¬ÁÏÍø and the Hospital District of Helsinki and Uusimaa (HUS).

Join us!
2.3. klo 14:00-16:30 Biomedicum 1, Haartmaninkatu 8, ground floor.

For more information, please contact:

³¢¾±²õä³Ù¾±±ð³Ù´Ç²¹:
Tuula Palmén, Head of project office, Health Capital Helsinki
tel. 050 4617 290
tuula.palmen@healthcapitalhelsinki.fi

Markus Mäkelä
911±¬ÁÏÍø
tel. 050 5207 770
markus.m.makela@aalto.fi   

Health Capital Helsinki (HCH) is a research, know-how and entrepreneurship cluster in the fields of life science and health technology in the Helsinki region.  911±¬ÁÏÍø, the University of Helsinki and the Hospital district of Helsinki and Uusimaa form an alliance that, based on the research in these fields, develops the innovation and business environment, with an aim to make the Helsinki region the leading Nordic region in the fields of health and wellbeing. The development measures are coordinated by the Health Capital Helsinki project office.